<bill session="116" type="h" number="4439" updated="2023-01-11T13:45:08Z">
  <state datetime="2020-09-29T16:43:24-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2020-09-29T16:43:24-04:00"/>
  </status>
  <introduced datetime="2019-09-20"/>
  <titles>
    <title type="display">Creating Hope Reauthorization Act</title>
    <title type="short" as="introduced">Creating Hope Reauthorization Act</title>
    <title type="short" as="reported to house">Creating Hope Reauthorization Act</title>
    <title type="short" as="passed house">Creating Hope Reauthorization Act</title>
    <title type="short" as="passed house">Creating Hope Reauthorization Act</title>
    <title type="official" as="amended by house">To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to make permanent the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.</title>
  </titles>
  <sponsor bioguide_id="B001251"/>
  <cosponsors>
    <cosponsor bioguide_id="B001306" joined="2020-08-18"/>
    <cosponsor bioguide_id="B001300" joined="2020-04-23"/>
    <cosponsor bioguide_id="B001257" joined="2019-09-20"/>
    <cosponsor bioguide_id="B001303" joined="2020-03-11"/>
    <cosponsor bioguide_id="B001278" joined="2020-09-11"/>
    <cosponsor bioguide_id="B001274" joined="2020-08-18"/>
    <cosponsor bioguide_id="C001072" joined="2020-03-04"/>
    <cosponsor bioguide_id="C001103" joined="2020-07-29"/>
    <cosponsor bioguide_id="C001067" joined="2020-03-04"/>
    <cosponsor bioguide_id="C001068" joined="2020-08-14"/>
    <cosponsor bioguide_id="C001097" joined="2020-05-15"/>
    <cosponsor bioguide_id="D000619" joined="2020-03-04"/>
    <cosponsor bioguide_id="D000191" joined="2020-08-14"/>
    <cosponsor bioguide_id="D000197" joined="2019-10-04"/>
    <cosponsor bioguide_id="D000623" joined="2020-09-01"/>
    <cosponsor bioguide_id="E000179" joined="2019-09-20"/>
    <cosponsor bioguide_id="F000466" joined="2019-09-24"/>
    <cosponsor bioguide_id="F000449" joined="2020-09-01"/>
    <cosponsor bioguide_id="G000568" joined="2020-07-29"/>
    <cosponsor bioguide_id="H001067" joined="2019-09-20"/>
    <cosponsor bioguide_id="K000376" joined="2019-09-20"/>
    <cosponsor bioguide_id="K000385" joined="2019-09-20"/>
    <cosponsor bioguide_id="K000362" joined="2020-08-18"/>
    <cosponsor bioguide_id="K000382" joined="2020-07-29"/>
    <cosponsor bioguide_id="L000589" joined="2020-09-01"/>
    <cosponsor bioguide_id="L000397" joined="2020-08-18"/>
    <cosponsor bioguide_id="L000591" joined="2020-02-25"/>
    <cosponsor bioguide_id="M001203" joined="2020-08-18"/>
    <cosponsor bioguide_id="M001158" joined="2020-08-21"/>
    <cosponsor bioguide_id="M001198" joined="2020-07-30"/>
    <cosponsor bioguide_id="M001157" joined="2019-09-20"/>
    <cosponsor bioguide_id="M001200" joined="2020-09-01"/>
    <cosponsor bioguide_id="M001159" joined="2020-02-25"/>
    <cosponsor bioguide_id="M001190" joined="2019-09-20"/>
    <cosponsor bioguide_id="P000618" joined="2020-08-21"/>
    <cosponsor bioguide_id="R000515" joined="2019-09-20"/>
    <cosponsor bioguide_id="R000609" joined="2020-03-04"/>
    <cosponsor bioguide_id="S001207" joined="2020-09-11"/>
    <cosponsor bioguide_id="S001200" joined="2020-04-23"/>
    <cosponsor bioguide_id="S001175" joined="2019-09-20"/>
    <cosponsor bioguide_id="W000795" joined="2020-09-15"/>
    <cosponsor bioguide_id="W000810" joined="2020-08-14"/>
  </cosponsors>
  <actions>
    <action datetime="2019-09-20">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-09-20" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-09-23">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2020-09-09">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2020-09-09" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </action>
    <action datetime="2020-09-29">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-551.</text>
    </action>
    <calendar datetime="2020-09-29" calendar="Union" number="451">
      <text>Placed on the Union Calendar, Calendar No. 451.</text>
    </calendar>
    <action datetime="2020-09-29T16:29:37-04:00">
      <text>Mr. Pallone moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2020-09-29T16:29:58-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H5023-5025" label="consideration"/>
    </action>
    <action datetime="2020-09-29T16:30:01-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 4439.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2020-09-29T16:43:24-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H5023" label="text"/>
    </vote>
    <action datetime="2020-09-29T16:43:26-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2020-09-29T16:43:27-04:00">
      <text>The title of the measure was amended. Agreed to without objection.</text>
    </action>
    <action datetime="2020-09-30">
      <text>Received in the Senate.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Markup, Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="4010" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Child health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Infectious and parasitic diseases"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-10T13:09:28Z" status="Passed House">Creating Hope Reauthorization Act

This bill reauthorizes a Food and Drug Administration (FDA) program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)

Specifically, the bill reauthorizes the program through FY2024, but the FDA may award a voucher afterwards in certain instances.</summary>
  <committee-reports>
    <report>H. Rept. 116-551</report>
  </committee-reports>
</bill>
